Imperial College London Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
Life Science Zurich Graduate School Featured PhD Programmes
"drugs" AND "design"×
10 miles

Pharmaceutical / Medicinal Chemistry (drugs design) PhD Projects, Programs & Scholarships

We have 11 Pharmaceutical / Medicinal Chemistry (drugs design) PhD Projects, Programs & Scholarships

  • "drugs" AND "design" ×
  • Pharmaceutical / Medicinal Chemistry×
  • clear all
Order by 
Showing 1 to 11 of 11
  Development of Novel 3D-Printable Chemical Reaction and Separations Technologies for Continuous Flow Synthesis of Drugs
  Dr S Ferguson
Application Deadline: 1 July 2020

Funding Type

PhD Type

In recent years flow chemistry and continuous manufacturing have been the object of increasing interest in the pharmaceutical industry.
  Fundamentals of the Chromatographic Separation Processes of Peptide Therapeutics
  Prof D Williams
Applications accepted all year round

Funding Type

PhD Type

Imperial College are inviting applications for a PhD position to join an exciting new Engineering and Physical Sciences Research Council (EPSRC) Prosperity Partnership between Imperial, UCL and Eli Lilly on Transforming synthetic drug manufacturing.
  Microfluidic Synthesis of Nanomedicines for the Delivery of Biologic Drugs
  Dr D Lamprou
Applications accepted all year round

Funding Type

PhD Type

Progress in drug design has led to the development of new molecules. However, the limited ability to selectively deliver these molecules at well-defined dosing regimens remains a significant challenge.
  Solubility and Crystallisation of Peptides
  Dr J Heng
Applications accepted all year round

Funding Type

PhD Type

Imperial College are inviting applications for a PhD position to join an exciting new Engineering and Physical Sciences Research Council (EPSRC) Prosperity Partnership between Imperial, UCL and Eli Lilly on Transforming synthetic drug manufacturing.
  Development of antiviral peptidomimetic enzyme inhibitors
  Dr L Trembleau, Dr H Deng
Applications accepted all year round

Funding Type

PhD Type

Coronaviruses are a large group of viruses that circulate and evolve among various animals. They can cause mild human illnesses such as the common cold or more serious respiratory diseases as seen in the recent outbreaks of SARS (2002), MERS (2012), and COVID-19 (2019).
  PhD Student in Organic/Medicinal Chemistry (New Antibiotics)
  Dr A Titz
Applications accepted all year round

Funding Type

PhD Type

The Helmholtz Association is the largest research organisation in Germany with over 40.000 employees. The Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) was founded between the Helmholtz Centre for Infection Research (HZI) and Saarland University in 2009.
  Nutrient-Mediated Delivery of ‘Dual Warhead’ Antimicrobials
  Dr A Routledge, Prof A-K Duhme-Klair
Applications accepted all year round

Funding Type

PhD Type

Microbial resistance to antibiotics is a growing problem. Until recently, antibiotics of the fluoroquinolone-type provided some of the most active broad-spectrum antibacterial agents on the market.
  Toward developing next-generation therapeutics - targeting the undruggable interactome
  Dr W Houssen, Prof M Jaspars, Dr L Trembleau
Applications accepted all year round

Funding Type

PhD Type

Cyclic and modified cyclic peptides are very appealing scaffolds especially as therapeutics with several examples reach the clinic e.g.
  Pharmaceutical Materials
  Dr A Erxleben
Application Deadline: 1 September 2020

Funding Type

PhD Type

Applications are invited for a fully funded PhD position( €18,500 per annum stipend plus €5,500 tuition fee)s in the pharmaceutical and medicinal chemistry group led by Dr Andrea Erxleben at the National University of Ireland, Galway.
  Computer Simulations of G protein-coupled Receptors
  Dr I Tikhonova
Applications accepted all year round

Funding Type

PhD Type

Many physiological processes are controlled through the activation of G protein-coupled receptors (GPCRs) by regulatory peptides, making peptide GPCRs particularly useful targets for major human diseases such as diabetes and CNS diseases.
  Nanotechnologies for cancer: developing new polymer-drug conjugates for the treatment of a range of cancers
  Dr F Greco, Prof H Osborn
Applications accepted all year round

Funding Type

PhD Type

Polymer anticancer-drug conjugates are drug delivery systems in which a low molecular weight anticancer agent is covalently conjugated to a water-soluble polymeric carrier.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2020
All rights reserved.